Abstract Background Oritavancin. a long-acting lipoglycopeptide approved for use in acute bacterial skin and skin structure infections. has limited data evaluating use in serious infections due to Gram-positive organisms. We aimed to assess the effectiveness and safety of oritavancin for consolidative treatment of Gram-positive bloodstream infections (BSI). https://thebookmarkid.com/story19599739/fat-stores-and-antioxidant-capacity-affect-stopover-decisions-in-three-of-four-species-of-migratory-passerines-with-different-migration-strategies-an-experimental-approach